Item 9A. Controls and Procedures
ITEM
9A. CONTROLS AND PROCEDURES
Evaluation of Disclosure
Controls and Procedures
Based on our management’s
evaluation (with the participation of our Principal Executive Officer and Principal Financial Officer) of the effectiveness of our disclosure
controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”),
our Principal Executive Officer and Principal Financial Officer have concluded that, as of December 31, 2020, in light of the material
weaknesses described below, certain of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the
Exchange Act) were not effective to ensure that the information required to be disclosed in the reports that we file or submit under
the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms,
and that such information is accumulated and communicated to management as appropriate to allow timely decisions regarding required disclosure
as of December 31, 2020. See the material weaknesses discussed below in Management’s Annual Report on Internal Control over Financial
Reporting.
Management’s Report
on Internal Control over Financial Reporting
Our management is responsible
for establishing and maintaining adequate internal controls over financial reporting, as such term is defined in Rule 13a-15(f)
under the Exchange Act. Based on our management’s evaluation (with the participation of our Principal Executive Officer and Principal
Financial Officer), of the effectiveness of our internal controls over financial reporting as of December 31, 2020, which was based
on the framework in the Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission,
our Principal Executive Officer and Principal Financial Officer have concluded that, as of December 31, 2020, in light of the material
weaknesses described below, our internal control over financial reporting was not effective as of December 31, 2020.
As a result of the assessment
described above, we identified control deficiencies that constitute material weaknesses in the design and operation of our internal control
over financial reporting. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting,
such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements
will not be prevented or detected on a timely basis.
50
The following material
weaknesses, which were discovered to be material during 2020, were present at December 31, 2020: (a) segregation of duties (resulting
from the small number of individuals performing the accounting functions), including the lack of a formal journal entry review and approval
process; (b) the design and operation of our information technology general controls; and (c) our overall closing and financial
reporting processes, including accounting for significant and unusual transactions. In light of the restatement discussed herein, the
Company has reassessed the effectiveness of its internal controls over its financial reporting processes as of December 31, 2020, and
has concluded that its remediation plan of its previously disclosed material weaknesses will be expanded to address controls in the determination
of the appropriate accounting for complex financial instruments. Our remediation plans regarding the material weaknesses are addressed
below.
Remediation
To remediate the remaining
material weaknesses described above, we are implementing and/or plan to implement the following:
● To
alleviate the information technology controls issue, the Company plans to implement NetSuite,
an Oracle cloud-based ERP and financial solution. This solution will allow personnel to implement
workflow controls.
●
To
alleviate the segregation of duties issue, the Company plans to leverage NetSuite configuration and workflow while expanding the
accounting team and reviewing roles;
●
To
alleviate the lack of a formal journal entry review and approval process, the Company will be implementing workflow steps within
NetSuite to ensue all journal entries are approved before posting to the general ledger;
●
To
alleviate the weakness in the overall closing and financial reporting processes, including accounting for significant and unusual
transactions, the Company has hired additional internal legal and accounting support, as well as engaging RSM US LLP to assist with
technical matters during 2020; and
●
To
alleviate the financial reporting issue over complex financial instruments, the Company will enhance our processes to identify and
appropriately apply applicable accounting requirements for complex accounting standards, including providing enhanced access to accounting
literature, research materials and increased communication among our personnel and third-party professionals with whom we consult
regarding complex accounting applications.
When fully implemented and
operational, we believe the measures described above will remediate the remaining material weaknesses we have identified and strengthen
our internal control over financial reporting, however, the material weakness will not be considered remediated until management has
concluded, through testing, that these controls are effective. Notwithstanding the identified material weaknesses, management believes
that the consolidated financial statements included in this Annual Report on Form 10-K present fairly, in all material respects, our
financial position, results of operations, and cash flows as of and for the periods presented in accordance with U.S. GAAP.
Changes in Internal Control
over Financial Reporting
As discussed above, we are
implementing certain measures to remediate the material weaknesses identified in the design and operation of our internal control over
financial reporting. Other than those measures, there have been no changes in our internal control over financial reporting (as such
term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended December 31, 2020 that have materially
affected, or are reasonably likely to materially affect, our internal control over financial reporting.
ITEM
9B. OTHER INFORMATION
The Company currently plans
to hold its 2021 Annual Meeting of Stockholders on June 8, 2021. Pursuant to the terms of the Company’s Bylaws, for any stockholder
to bring business (other than pursuant to and in compliance with Exchange Act Rule 14a-8) or make a nomination before the annual meeting,
the stockholder must deliver notice to the Secretary of the Company not later than the close of business on the 90th day nor earlier
than the close of business on the 120th day before the anniversary date of the immediately preceding annual meeting of stockholders;
provided, however, that in the event that the annual meeting is more than 30 days before or more than 60 days after such anniversary
date, notice by the stockholder to be timely must be so received no earlier than the close of business on the 120th day before the meeting
and not later than the later of (x) the close of business on the 90th day before the meeting or (y) the close of business on the 10th
day following the day on which public announcement of the date of the annual meeting is first made by the Company. Because the Company
did not hold an annual meeting last year, the Company has determined that the date by which stockholders must deliver such notice for
the purposes of the 2021 Annual Meeting of Stockholders is March 10, 2021, which is 90 days prior to the anticipated date of the 2021
Annual Meeting of Stockholders. Pursuant to Rule 14a-8, for a stockholder to submit a proposal for inclusion in the Company’s proxy
materials for the 2021 Annual Meeting of Stockholders, the stockholder must comply with the requirements set forth in Rule 14a-8 including
with respect to the subject matter of such proposal and must deliver the proposal and all required documentation to the Company a reasonable
time before the Company begins to print and sent its proxy materials for the meeting. For the purposes of the 2021 Annual Meeting of
Stockholders, the Company has determined that March 6, 2021 is a reasonable time before the Company plans to begin printing and mailing
its proxy materials. The public announcement of an adjournment or postponement of the 2021 Annual Meeting date will not commence a new
time period (or extend any time period) for giving such notice under the Company’s Bylaws or submitting a proposal pursuant to
Rule 14a-8.
51
Part
III
ITEM
10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
The information required
by Item 10 will be contained in, and is hereby incorporated by reference to, our definitive proxy statement for the 2021 Annual Meeting
of Stockholders (the “2021 Proxy Statement”), which we will file pursuant to Regulation 14A with the Commission within 120
days after the close of the year ended December 31, 2020. This includes information regarding our Code of Business Conduct and Ethics.
ITEM
11. EXECUTIVE COMPENSATION
The information required
by Item 11 will be contained in, and is hereby incorporated by reference to, the 2021 Proxy Statement, which we will file pursuant to
Regulation 14A with the Commission within 120 days after the close of the year ended December 31, 2020.
ITEM
12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
The information required
by Item 12 will be contained in, and is hereby incorporated by reference to, the 2021 Proxy Statement, which we will file pursuant to
Regulation 14A with the Commission within 120 days after the close of the year ended December 31, 2020.
ITEM
13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
The information required
by Item 13 will be contained in, and is hereby incorporated by reference to, the 2021 Proxy Statement, which we will file pursuant to
Regulation 14A with the Commission within 120 days after the close of the year ended December 31, 2020.
ITEM
14. PRINCIPAL ACCOUNTING FEES AND SERVICES
The information required
by Item 14 will be contained in, and is hereby incorporated by reference to, the 2021 Proxy Statement, which we will file pursuant to
Regulation 14A with the Commission within 120 days after the close of the year ended December 31, 2020.
52
Part
IV
ITEM
15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES
(a)(1) and (a)(2) Financial Statements and Financial Statement
Schedules:
Reference is made to the Index to Financial Statements
of the Company under Item 8 of Part II. All financial statement schedules are omitted because they are not applicable, or the amounts
are immaterial, not required, or the required information is presented in the financial statements and notes thereto in Item 8 of Part
II above.
(b) Exhibits
Exhibits: The exhibits listed in the accompanying
index to exhibits are filed or incorporated by reference as part of this Annual Report on Form 10-K. Exhibits not incorporated by reference
to a prior filing are designated by an asterisk (*); all exhibits not so designated are incorporated by reference to a prior filing as
indicated.
Exhibit
Number
Description
2.1+
Business
Combination Agreement and Plan of Reorganization, dated as of June 18, 2020, by and among Tortoise Acquisition Corp., SHLL Merger
Sub Inc. and Hyliion Inc. (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K (File No. 001-38823)
filed with the SEC on June 19, 2020).
3.1
Second
Amended and Restated Certificate of Incorporation of the Company, dated October 1, 2020 (incorporated by reference to Exhibit 3.1
to the Company’s Current Report on Form 8-K (File No. 001-38823) filed with the SEC on October 7, 2020).
3.2
Amended
and Restated Bylaws of the Company, dated October 1, 2020 (incorporated by reference to Exhibit 3.2 to the Company’s Current
Report on Form 8-K (File No. 001-38823) filed with the SEC on October 7, 2020).
4.1
Form
of Common Stock Certificate of the Company (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form
8-K (File No. 001-38823) filed with the SEC on October 7, 2020).
4.2
Form
of Warrant Certificate of the Company (incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K
(File No. 001-38823) filed with the SEC on October 7, 2020).
4 .3
Warrant
Agreement, dated February 27, 2019, between the Company and Continental Stock Transfer & Trust Company, as warrant agent (incorporated
by reference to Exhibit 4.1 to the Current Report on Form 8-K filed on March 5, 2019).
4 .4
Amended
and Restated Registration Rights Agreement, dated October 1, 2020, by and among the Company and certain stockholders of the Company
(incorporated by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K (File No. 001-38823) filed with the SEC
on October 7, 2020).
4.3
Form
of Lock-Up Agreement (incorporated by reference to Exhibit 4.6 to the Company’s Current Report on Form 8-K (File No. 001-38823)
filed with the SEC on October 7, 2020).
4.4*
Description
of Securities.
4.5
Lock-Up
Agreement, dated October 1, 2020, by and between the Company and Thomas Healy (incorporated by reference to Exhibit 4.6 to the Company’s
Current Report on Form 8-K (File No. 001-38823) filed with the SEC on October 7, 2020).
10.1
Lease
Agreement, dated February 5, 2018, by and between IGX Brushy Creek, LLC and Hyliion Inc. (incorporated by reference to Exhibit 10.9
to the Current Report on form 8-K filed on October 7, 2020).
10.2
Letter
Agreement, dated February 27, 2019, among Tortoise Acquisition Corp., its officers and directors, Tortoise Sponsor LLC, Tortoise
Borrower LLC and Atlas Point Energy Infrastructure Fund, LLC (incorporated by reference to Exhibit 10.1 to the Company’s Current
Report on Form 8-K (File No. 001-38823) filed with the SEC on March 5, 2019).
10.3
Investment
Management Trust Agreement, dated February 27, 2019, between Tortoise Acquisition Corp. and Continental Stock Transfer & Trust
Company, as trustee (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K (File No. 001-38823)
filed with the SEC on March 5, 2019).
10.4
Registration
Rights Agreement, dated February 27, 2019, among Tortoise Acquisition Corp., its officers and directors, Tortoise Sponsor LLC, Tortoise
Borrower LLC and Atlas Point Energy Infrastructure Fund, LLC (incorporated by reference to Exhibit 10.3 to the Company’s Current
Report on Form 8-K (File No. 001-38823) filed with the SEC on March 5, 2019).
10.5
Administrative
Services Agreement, dated February 27, 2019, between Tortoise Acquisition Corp. and Tortoise Sponsor LLC (incorporated by reference
to Exhibit 10.4 to the Company’s Current Report on Form 8-K (File No. 001-38823) filed with the SEC on March 5, 2019).
10.6
Private
Placement Warrants Purchase Agreement, dated February 27, 2019, between Tortoise Acquisition Corp. and Tortoise Borrower LLC (incorporated
by reference to Exhibit 10.5 to the Company’s Current Report on Form 8-K (File No. 001-38823) filed with the SEC on March 5,
2019).
10.7
Forward
Purchase Agreement, dated November 21, 2018, among Tortoise Acquisition Corp., Tortoise Sponsor LLC and Atlas Point Energy Infrastructure
Fund, LLC (incorporated by reference to Exhibit 10.9 to the Company’s Registration Statement on Form S-1 (File No. 333-229537)
filed with the SEC on February 6, 2019).
10.7(a)
First
Amendment to Amended and Restated Forward Purchase Agreement, dated as of June 18, 2020, by and among Tortoise Acquisition Corp.,
Tortoise Sponsor LLC and Atlas Point Energy Infrastructure Fund, LLC (incorporated by reference to Exhibit 10.4 to the Company’s
Current Report on Form 8-K (File No. 001-38823) filed with the SEC on June 19, 2020).
10.8
Amended
and Restated Forward Purchase Agreement, dated February 6, 2019, among Tortoise Acquisition Corp., Tortoise Sponsor LLC and Atlas
Point Energy Infrastructure Fund, LLC (incorporated by reference to Exhibit 10.10 to the Company’s Registration Statement on
Form S-1 (File No. 333-229537) filed with the SEC on February 6, 2019).
10.9
Stockholder
Support Agreement, dated as of June 18, 2020, by and among Tortoise Acquisition Corp. and the stockholders of the Company named therein
(incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (File No. 001-38823) filed with the
SEC on June 19, 2020).
53
10.10
Stockholders
Rights Agreement, dated as of June 18 ,2020, by and among Tortoise Acquisition Corp., Vincent T. Cubbage, Stephen Pang and the stockholders
of the Company named therein (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K (File No.
001-38823) filed with the SEC on June 19, 2020).
10.11
Form
of Subscription Agreement (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K (File No.
001-38823) filed with the SEC on June 19, 2020).
10.12
Form
of Indemnification Agreement between the Company and its directors and officers (incorporated by reference to Exhibit 10.4 to the
Company’s Current Report on Form 8-K (File No. 001-38823) filed with the SEC on October 7, 2020).
10.13†
Hyliion
Inc. 2016 Equity Incentive Plan (incorporate by references to Exhibit 99.2 to the Company’s Registration Statement on Form
S-8 (File No. 333-251328) filed with the SEC on December 14, 2020 ).
10.13(a)†
Hyliion
Inc. 2016 Equity Incentive Plan, Form of Incentive Stock Option Agreement (incorporated by reference to Appendix D to the foregoing
2016 Equity Incentive Plan).
10.13(b)†
Hyliion
Inc. 2016 Equity Incentive Plan, Form of Non-statutory Stock Option Agreement (incorporated by reference to Appendix E to the foregoing
2016 Equity Incentive Plan).
10.13(c)†
Hyliion
Inc. 2016 Equity Incentive Plan, Form of Stock Restriction Agreement (incorporated by reference to Appendix F to the foregoing 2016
Equity Incentive Plan).
10.14†
Hyliion
Holdings Corp. 2020 Equity Incentive Plan (incorporated by reference to Exhibit 10.5 to the Company’s Current Report on Form
8-K (File No. 001-38823) filed with the SEC on October 7, 2020).
10.14(a)†
Hyliion
2020 Equity Incentive Plan, Form of Stock Option Agreement (incorporated by reference to Exhibit 99.3 to the Company’s Registration
Statement on Form S-8 (File No. 333-251328) filed with the SEC on December 14, 2020).
10.14(b)†
Hyliion
2020 Equity Incentive Plan, Form of RSU Award Agreement (incorporated by reference to Exhibit 99.4 to the Company’s Registration
Statement on Form S-8 (File No. 333-251328) filed with the SEC on December 14, 2020).
10.15†
Employment
Agreement, dated October 23, 2020, by and between the Company and Greg Van de Vere (incorporated by reference to Exhibit 10.7 to
the Company’s Registration Statement on Form S-1 (File No. 333-249649) filed with the SEC on October 23, 2020).
10.16†
Employment
Agreement, dated December 2, 2020, by and between Hyliion Holdings Corp. and Thomas Healy (incorporated by reference to Exhibit 10.1
to the Company’s Current Report on Form 8-K (File No. 001-38823) filed with the SEC on December 7, 2020).
10.17†
Employment
Agreement, dated December 2, 2020, by and between Hyliion Holdings Corp. and Patrick Sexton (incorporated by reference to Exhibit
10.2 to the Company’s Current Report on Form 8-K (File No. 001-38823) filed with the SEC on December 7, 2020).
10.18*†
Employment
Agreement, dated January 8, 2021, by and between Hyliion Holdings Corp. and Sherri Baker.
14.1*
Code of Business Conduct
and Ethics.
16.1
Letter
from WithumSmith+Brown, PC to the SEC, dated October 1, 2020 (incorporated by reference to Exhibit 16.1 to the Company’s Current
Report on Form 8-K (File No. 001-38823) filed with the SEC on October 7, 2020) .
21.1*
List of Subsidiaries.
23.1*
Consent
of Grant Thornton Independent Registered Public Accounting Firm.
31.1*
Certification
of Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant
to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*
Certification
of Principal Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant
to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*
Certification
of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002.
32.2*
Certification
of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002.
101.INS*
XBRL Instance Document
101.SCH*
XBRL Taxonomy Extension
Schema Document
101.CAL*
XBRL Taxonomy Calculation
Linkbase Document
101.DEF*
XBRL Taxonomy Definition
Linkbase Document
101.LAB*
XBRL Taxonomy Extension
Label Linkbase Document
101.PRE*
XBRL Taxonomy Extension
Presentation Linkbase Document
104
Cover Page Interactive
Data File (formatted as inline XBRL)
* Filed
herewith.
† Indicates
a management contract or compensatory plan or arrangement, as required by Item 15(a)(3).
+ The
schedules and exhibits to this agreement have been omitted pursuant to Item 601(a)(5) of
Regulation S-K. A copy of any omitted schedule and/or exhibit will be furnished to the SEC
upon request.
ITEM
16. FORM 10-K SUMMARY
None.
54
SIGNATURES
Pursuant to the requirements
of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
HYLIION HOLDINGS CORP.
Date: May 17, 2021
By:
/s/ Thomas Healy
Thomas Healy
President and Chief Executive Officer
Pursuant to the requirements of the Securities
Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and
on the dates indicated.
Signature
Title
Date
/s/
Thomas Healy
President
and Chief Executive Officer and Director
(Principal Executive Officer)
May
17, 2021
Thomas
Healy
/s/
Sherri Baker
Chief
Financial Officer
(Principal Financial Officer and Principal Accounting Officer)
May
17, 2021
Sherri
Baker
/s/
Andrew H. Card, Jr.
Director
May
17, 2021
Andrew
H. Card, Jr.
/s/
Vincent T. Cubbage
Director
May
17, 2021
Vincent
T. Cubbage
/s/
Howard Jenkins
Director
May
17, 2021
Howard
Jenkins
/s/
Edward Olkkola
Chairman
May
17, 2021
Edward
Olkkola
/s/
Stephen Pang
Director
May
17, 2021
Stephen
Pang
/s/
Robert M. Knight, Jr.
Director
May
17, 2021
Robert
M. Knight, Jr.
55